CIPROFLOXACIN HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ciprofloxacin Hydrochloride, and what generic alternatives are available?
Ciprofloxacin Hydrochloride is a drug marketed by Altaire Pharms Inc, Amring Pharms, Fdc Ltd, Rising, Rubicon, Sciegen Pharms Inc, The J Molner, Watson Labs Inc, Aiping Pharm Inc, Amneal, Aurobindo Pharma, Barr, Carlsbad, Chartwell, Dr Reddys Labs Ltd, Hikma, Ivax Sub Teva Pharms, Natco, Nostrum Labs, Pliva, Sun Pharm Inds Ltd, Taro, Teva, Unique, Watson Labs, and Yiling. and is included in twenty-seven NDAs.
The generic ingredient in CIPROFLOXACIN HYDROCHLORIDE is ciprofloxacin hydrochloride. There are thirty-four drug master file entries for this compound. Fifty-six suppliers are listed for this compound. Additional details are available on the ciprofloxacin hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ciprofloxacin Hydrochloride
A generic version of CIPROFLOXACIN HYDROCHLORIDE was approved as ciprofloxacin hydrochloride by RUBICON on June 9th, 2004.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CIPROFLOXACIN HYDROCHLORIDE?
- What are the global sales for CIPROFLOXACIN HYDROCHLORIDE?
- What is Average Wholesale Price for CIPROFLOXACIN HYDROCHLORIDE?
Summary for CIPROFLOXACIN HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 26 |
| NDAs: | 27 |
| Finished Product Suppliers / Packagers: | 51 |
| Raw Ingredient (Bulk) Api Vendors: | 110 |
| Clinical Trials: | 301 |
| Patent Applications: | 3,036 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for CIPROFLOXACIN HYDROCHLORIDE |
| What excipients (inactive ingredients) are in CIPROFLOXACIN HYDROCHLORIDE? | CIPROFLOXACIN HYDROCHLORIDE excipients list |
| DailyMed Link: | CIPROFLOXACIN HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for CIPROFLOXACIN HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Institute of Cancer Research, United Kingdom | Phase 1/Phase 2 |
| Prostate Cancer Foundation | Phase 1/Phase 2 |
| Shanghai Pulmonary Hospital, Shanghai, China | Phase 4 |
Pharmacology for CIPROFLOXACIN HYDROCHLORIDE
| Drug Class | Fluoroquinolone Antibacterial Quinolone Antimicrobial |
| Mechanism of Action | Cytochrome P450 1A2 Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for CIPROFLOXACIN HYDROCHLORIDE
US Patents and Regulatory Information for CIPROFLOXACIN HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nostrum Labs | CIPROFLOXACIN HYDROCHLORIDE | ciprofloxacin hydrochloride | TABLET;ORAL | 076138-003 | Jun 9, 2004 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hikma | CIPROFLOXACIN HYDROCHLORIDE | ciprofloxacin hydrochloride | TABLET;ORAL | 076558-004 | Jun 9, 2004 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sun Pharm Inds Ltd | CIPROFLOXACIN HYDROCHLORIDE | ciprofloxacin hydrochloride | TABLET;ORAL | 075747-002 | Jun 9, 2004 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
